Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure

NCT04396899 is registered in ClinicalTrials.gov with University Medical Center Goettingen as lead sponsor.

NCT NCT04396899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04396899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure
Lead sponsor
University Medical Center Goettingen
Phase
Phase 1/2
Overall status
Recruiting
Start date
February 3, 2020
Completion date
December 31, 2027
Enrollment
53 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure